Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Sponsorship provides a year of access to MBC BioLabs' life-science incubators and in-house Astellas expertise for scientific innovators TOKYO and SAN FRANCISCO, Sept. 21, 2021 /PRNewswire/ --...
Astellas' "Future Innovator Prize" sponsorship provides access to life-science incubator and in-house Astellas expertise for scientific entrepreneurs with cutting-edge ideas CAMBRIDGE, Mass., Aug....
- PROGRAF Becomes First Immunosuppressive Drug Approved in the U.S. for People Receiving a Lung Transplant - NORTHBROOK, Ill., July 20, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503,...
- Three innovators awarded $200,000 in total grants and resources for their work to "Change Cancer Care" beyond medicine - NORTHBROOK, Ill., March 24, 2021 /PRNewswire/ -- Astellas Pharma US, Inc....
Read more about Astellas Oncology Announces Grand Prize Winner of Fifth Annual C³ Prize® Challenge
Oncology head Mark Reisenauer named Astellas US President; Masahide Goto named President at Astellas Institute for Regenerative Medicine NORTHBROOK, Ill. and BOSTON, Feb. 4, 2021 /PRNewswire/ --...
Follow U.S. news
